Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Lloyd Paul Aiello(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Louis R. Pasquale(Outcomes Research Consortium), Mami Iwamoto(Brigham and Women's Hospital), Henry Jampel(Institute for Advanced Study), Paul G. Arrigg(Harvard University), Robert L. Avery(California Retina Consultants), Bruce A. Keyt, Hagen Thieme(Joslin Diabetes Center), Van Hung Nguyen(Hanoi Medical University Hospital), Napoleone Ferrara(Unknown), Lloyd M. Aiello(Joslin Diabetes Center), Sabera T. Shah(Harvard University), John E. Park(Boehringer Ingelheim (Germany))
Cited by 3,789
Related Papers
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
|Endocrine Reviews|2004|3.7k
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
|Journal of Biological Chemistry|1998|2k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k